
recently, The 15th Jinfeng Academic Eminent Forum was successfully held. This issue focuses on "Immunity, Metabolism and Redox Microenvironment Regulation". Distinguished Professor Zhao Qinjian of the School of Pharmacy of Chongqing Medical University, Professor Bu Pengcheng of the Institute of Biophysics, Chinese Academy of Sciences, and Professor Wu Hua of Suzhou University are invited as guest speakers. Professor Hu Biao and Professor Liang Li, PIs of the laboratory, are hosted. The participating scientific researchers conducted in-depth discussions on immune regulation, metabolic remodeling and redox microenvironment, creating a strong academic atmosphere.
Topic 1: Synchronous regulation of dual pathways to rebuild immunity and redox balance

Introduction to the speaker
Zhao Qinjian, National-level talents, Chongqing outstanding scientists, and Chongqing academic and technological leaders. Served as a member of several WHO vaccine-related expert groups including the WHO Strategic Advisory Group on Immunization ; He is currently the founding director of the Chongqing University Engineering Research Center for Immunological Products and Biomimetic Drugs, a distinguished professor at the School of Pharmacy of Chongqing Medical University, a distinguished researcher at the Chongqing Institute of Information and Smart Medicine, a member of the Chinese Medical Association, a member of the Special Committee on Biopharmaceuticals and Quality Research of the Chinese Pharmaceutical Association, and a technical expert on major biomedicine projects in Chongqing. Hosted 1 major national 863 project during the 12th Five-Year Plan, 4 National Natural Science Foundation general projects, 1 national foreign expert project, and participated in 1 national key natural science project as a core backbone ; He serves on the editorial board of npj Vaccine, Human Vaccines & Immunotherapeutics and other vaccine journals.
Key points of the lecture
This lecture Focusing on "synchronous regulation of dual pathways to rebuild immunity and redox balance", it focuses on the immunomodulatory effects of aluminum, manganese and other metal elements and the potential value of the NRF2 antioxidant pathway. Combined with disease models such as psoriasis, multiple sclerosis, and renal fibrosis, the application of multi-omics analysis and novel molecular modular design in the discovery and structure optimization of candidate compounds was shared. Aiming at the pain points of the interaction between immune imbalance and oxidative stress and the limited effect of single-pathway intervention in autoimmune and inflammatory diseases, the report proposes a multi-target collaborative regulation strategy and explores the application prospects of this strategy in the development of innovative natural product drugs and intervention of immune-related diseases, providing new ideas for the design of multi-target drugs. 。
Topic 2: Metabolic regulation and intervention strategies for tumor progression

Introduction to the speaker
Bu Pengcheng, Institute of Biophysics, Chinese Academy of Sciences, second-level researcher, doctoral supervisor. Chief scientist of the National Key R&D Program, Leading Talents of the Ten Thousand Talents Program, Young and Middle-aged Innovation Leading Talents of the Ministry of Science and Technology, National Youth Thousand Talents Program, and Chinese Academy of Sciences Hundred Talents Program. He successively engaged in postdoctoral research at the University of California, Berkeley, Cornell University and Duke University. Mainly engaged in research on stem cells and tumor metabolism. He has presided over projects such as the National Key R&D Plan, the Four Major Chronic Disease Special Projects, the National Fund Committee’s Key Projects, the National Fund Committee’s Key Special Projects, and the Chinese Academy of Sciences’ Strategic Priority B Special Project. In recent years, he has published many research papers as the corresponding author (including co-authors) in Cell Metabolism (4 articles), Cell Stem Cell, Developmental Cell, JCI, Trends in Cell Biology and other magazines.
Key points of the lecture
This lecture focused on the molecular mechanism and targeted intervention strategies of colorectal cancer metastasis. Based on the intestinal cancer liver metastasis model, it was found that creatine supplementation can inhibit the in situ growth of intestinal cancer to a certain extent.; Dietary intake or GATM-mediated endogenous creatine synthesis can promote Smad2/3 activation through MPS1, thereby promoting tumor metastasis. Colorectal cancer cells upregulate ALDOB after colonizing the liver and use fructose to promote the growth of liver metastases. Fructose can also inhibit the differentiation of M1-like macrophages by regulating calcium signaling. The study further elucidated the tumor regulatory mechanism of CLMP and C6orf223, and used ferritin nanocarriers to deliver siRNA to inhibit tumor progression, providing a new theoretical basis for tumor prevention and treatment.
Topic 3: The occurrence and evolution of colorectal cancer and the regulation of immune microenvironment

Introduction to the speaker
Wu Hua, Professor, doctoral supervisor, and Zhongying Young Scholar of Suzhou University. He is currently a standing member of the Tumor Metastasis Professional Committee of the Chinese Anti-Cancer Association, a standing member of the Organoids and Organ Chip Professional Committee of the Chinese Anti-Cancer Association, a member of the Scientific Research Working Committee of the Pathology Branch of the Chinese Medical Association, a member of the Pathology Branch of the Jiangsu Provincial Medical Association, a standing member of the Molecular and Digital Pathology Professional Committee of the Jiangsu Provincial Research Hospital Association, and a member of the Pathology Committee of the China Medical Equipment Artificial Intelligence Alliance. Mainly dedicated to the study of the molecular pathological mechanisms of the occurrence and evolution of digestive tract tumors. Research results have been published in internationally renowned academic journals such as Nature Cancer, Nature Metabolism, PNAS, Cancer Research, etc. as independent corresponding or last corresponding author, and 3 authorized invention patents (first inventor). He has presided over more than ten national, provincial and ministerial level projects such as National Outstanding Youth and Jiangsu Province Outstanding Youth.
Key points of the lecture
This lecture Focusing on the mechanism of intestinal tumor metabolism and epigenetic immune regulation, it is pointed out that intestinal epithelial GSK3β drives the polarization of neutrophils toward the immunosuppressive T3 subpopulation through the metabolism-epigenetic axis of "H1FX degradation-glycolysis-lactate accumulation-fumarate accumulation-KDM2B inhibition-H3K36me2 elevation" and mediates ferroptosis resistance and immune escape through FTH1 and PD-L1.; The GSK3β inhibitor Tideglusib combined with a checkpoint blockade regimen can effectively reverse tumor immunosuppression. The study also found that lactic acid secreted by KRAS mutant intestinal cancer cells can be catalyzed by AARS1 to carry out extracellular lactation modification of CD44 on the surface of CD8⁺T cells, blocking AKT signaling and inhibiting the anti-tumor effect of CD8⁺T cells.
This lecture starts from The analysis of the basic mechanisms of tumors, the development of intelligent scientific research tools, and the application of cutting-edge technology platforms are progressing step by step. Faced with the key scientific issues in tumor immune transformation research, it brought multiple inspirations to the scientific researchers present in mechanism research, AI-assisted scientific research, and single-cell space technology applications. Participants said that the lecture content was close to the cutting edge, broadened research ideas, and gained a lot.